Evaluation of Early 5 to 6 Hours Iodine 123 Uptake for Diagnosis and Treatment Planning in Graves Disease
Document Type
Article
Publication Date
1995
Abstract
Background: Twenty-four-hour radioactive iodine uptake measurements necessitate extra visits and time delays in diagnostic confirmation of and therapy planning for hyperthyroid patients. We evaluated the early (5 to 6 hours) measurement of iodine 123 uptake (EU) to predict late (24 hours) uptake (LU) and assessed its value in the management of hyperthyroidism.
Methods: We conducted a prospective study in 51 previously untreated hyperthyroid and 27 euthyroid patients (initial evaluation group). Patients underwent both 6- and 24-hour123I uptake measurements. A subsequent 21 patients with Graves' disease (confirmation group) were evaluated in light of regression data generated in the initial evaluation group.
Results: An EU value of greater than 20% had a sensitivity of 100%, a specificity of 96%, and a positive predictive value of 98% for the diagnosis of hyperthyroidism and was superior to the most predictive LU value (>30%), which had a sensitivity of 98%, a specificity of 89%, and a positive predictive value of 94%, in distinguishing the hyperthyroid patients from euthyroid patients or those with subacute thyroiditis. Regression analysis revealed that the 24-hour uptake of the hyperthyroid patients could be predicted from the early measurement with the following formula: LU=28.94+0.584 (EU). The measured EU of the confirmation group was used to calculate a predicted LU with use of this formula. Measured LU and predicted LU correlated well (r=.85, Pr=.91, P
Conclusions: The EU of123I can replace 24-hour uptake measurements. Early uptake measurement is reliable and clinically useful for diagnosis confirmation and treatment planning in thyrotoxic patients.(Arch Intern Med. 1995;155:621-624)
Repository Citation
Hennessey, J. V.,
Berg, L. A.,
Ibrahim, M. A.,
& Markert, R. J.
(1995). Evaluation of Early 5 to 6 Hours Iodine 123 Uptake for Diagnosis and Treatment Planning in Graves Disease. Archives of Internal Medicine, 155 (6), 621-624.
https://corescholar.libraries.wright.edu/internal_medicine/43
DOI
10.1001/archinte.1995.00430060083010